Related Experiment Video
Updated: Dec 13, 2025
14:14
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
16.1K
Circulating Tumor Cell Detection Technologies and Clinical Utility: Challenges and Opportunities
Zeina Habli1, Walid AlChamaa1, Raya Saab2,3
1Neural Engineering and Nanobiosensors Group, Biomedical Engineering Program, Maroun Semaan Faculty of Engineering and Architecture, American University of Beirut, Beirut 1107 2020, Lebanon.
Cancers
|July 26, 2020
Summary
Circulating tumor cells (CTCs) offer valuable insights into cancer progression and metastasis. This review examines CTC detection technologies and their clinical utility, despite challenges in isolating these rare cells.
Area of Science:
- Oncology
- Biomarkers
- Cellular Biology
Background:
- Circulating tumor cells (CTCs) are shed from primary tumors into the bloodstream.
- CTCs carry critical information on tumor onset, progression, metastasis, and molecular characteristics.
- Emerging evidence supports CTCs as liquid biopsy biomarkers for cancer prognostication and treatment guidance.
Purpose of the Study:
- To review current preclinical technologies for detecting circulating tumor cells (CTCs).
- To analyze the advantages and limitations of various CTC sensing platforms.
- To survey and assess the published evidence on the clinical utility of CTCs in cancer management.
Main Methods:
- Review of preclinical CTC detection technologies.
- Analysis of sensing platforms for enumerating and isolating CTCs.
- Survey of clinical studies evaluating CTC utility.
Main Results:
- Various technologies exist for CTC detection, each with unique strengths and weaknesses.
- Challenges remain in isolating rare, heterogeneous CTCs for downstream analysis.
- Published evidence on CTC clinical utility shows mixed results, raising doubts about their value.
Conclusions:
- Despite technological advancements, robust clinical validation of CTCs is ongoing.
- Further research is needed to overcome isolation challenges and establish CTCs as reliable cancer biomarkers.
- Optimizing CTC detection and analysis is crucial for realizing their full clinical potential.
